Gefitinib is an EGFR inhibitor. It’s used for NSCLC patients who have either EGFR exon 19 deletions or the exon 21 L858R mutation. It works by stopping EGFR signaling.
The drug comes in 250 mg film-coated tablet form. You should take 250 mg once a day, whether you eat or not. Gefitinib comes in bottles with 30 tablets in each one.
